Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Metric Says You Are Smart to Buy Kindred Healthcare, Inc. (KND)

Page 1 of 2

Should Kindred Healthcare, Inc. (NYSE:KND) investors track the following data?

In the financial world, there are tons of indicators shareholders can use to monitor stocks. Some of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best money managers can outpace their index-focused peers by a superb margin (see just how much).

Just as key, optimistic insider trading sentiment is a second way to analyze the world of equities. Just as you’d expect, there are a variety of stimuli for a bullish insider to drop shares of his or her company, but only one, very clear reason why they would initiate a purchase. Many empirical studies have demonstrated the impressive potential of this strategy if you understand what to do (learn more here).

What’s more, we’re going to examine the recent info about Kindred Healthcare, Inc. (NYSE:KND).

How are hedge funds trading Kindred Healthcare, Inc. (NYSE:KND)?

In preparation for the third quarter, a total of 16 of the hedge funds we track were long in this stock, a change of 33% from the previous quarter. With hedgies’ capital changing hands, there exists a few noteworthy hedge fund managers who were increasing their holdings significantly.

Kindred Healthcare, Inc. (NYSE:KND)According to our 13F database, Chuck Royce’s Royce & Associates had the largest position in Kindred Healthcare, Inc. (NYSE:KND), worth close to $11.4 million, comprising less than 0.1%% of its total 13F portfolio. Sitting at the No. 2 spot is David Dreman of Dreman Value Management, with a $10.9 million position; 0.3% of its 13F portfolio is allocated to the stock. Some other peers with similar optimism include Nelson Obus’s Wynnefield Capital, Richard S. Meisenberg’s ACK Asset Management and Sean Cullinan’s Point State Capital.

With a general bullishness amongst the titans, specific money managers have been driving this bullishness. Royce & Associates, managed by Chuck Royce, created the most valuable position in Kindred Healthcare, Inc. (NYSE:KND). Royce & Associates had 11.4 million invested in the company at the end of the quarter. David Dreman’s Dreman Value Management also made a $10.9 million investment in the stock during the quarter. The other funds with new positions in the stock are Nelson Obus’s Wynnefield Capital, Richard S. Meisenberg’s ACK Asset Management, and Sean Cullinan’s Point State Capital.

Insider trading activity in Kindred Healthcare, Inc. (NYSE:KND)

Legal insider trading, particularly when it’s bullish, is most useful when the company in question has experienced transactions within the past six months. Over the latest 180-day time period, Kindred Healthcare, Inc. (NYSE:KND) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Kindred Healthcare, Inc. (NYSE:KND). These stocks are Assisted Living Concepts, Inc. (NYSE:ALC), Five Star Quality Care, Inc. (NYSE:FVE), Capital Senior Living Corporation (NYSE:CSU), The Ensign Group, Inc. (NASDAQ:ENSG), and National HealthCare Corporation (NYSEAMEX:NHC). This group of stocks are the members of the long-term care facilities industry and their market caps resemble KND’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!